Back to Portfolio


Tumor analysis and classification platform

has developed a next-generation tissue diagnostics platform for the analysis and classification of tumors and other solid tissues. Based on a proprietary microfluidic chip technology and a bench top device, the platform offers customers unprecedented speed, accuracy and flexibility.

Lunaphore’s unique solution meets today’s needs, where medicine is becoming more personalized and whole panels of biomarkers play an increasing role.


Homepage Facebook Twitter Linkedin 


Lunaphore in the News:

Lunaphore and Perkin Elmer announce collaboration

Lunaphore closes CHF 6m financing round

Four Redalpine companies among the Top 30 Swiss start-ups

Lunaphore's best pitch

Three Redalpine companies among the Top 10 Swiss start-ups

Knip, Trekksoft and Lunaphore among top 10 Swiss start-ups

Redalpine leads Series A round for revolutionary tissue diagnostics company Lunaphore


Jobs at Lunaphore